The trading panel analyzed how to trade Sanofi-Aventis' much discussed move for to acquire Genzyme.

Cramer says it's time for investors to stop selling at any sign of weakness and to return to a sane investing strategy.

Cramer said the company had a beautiful quarter.

Volume remains ultra-light while breadth was negative easing short-term overbought conditions.

Real estate investment trusts Duke Realty and Equity Residential TKTK